Trans medical care, FDA drug voucher program: Morning Rounds
The latest news in health and medicine is filled with controversy and groundbreaking developments. Let’s delve into the key highlights of the day.
The Trump administration has made a bold move to end gender-affirming care for transgender youth in the U.S. The Centers for Medicare and Medicaid Services have proposed rules that would withhold federal funds from facilities providing care for trans minors, including puberty blockers, hormones, and surgery. This decision has sparked outrage among patients and advocates, as it goes against decades of scientific consensus supporting the effectiveness of gender-affirming care.
In other news, the CDC has awarded a grant for a study on hepatitis B vaccines in West Africa, led by controversial Danish researchers. This study has raised ethical concerns and may not provide relevant data for vaccine use in the U.S. Additionally, the CDC panel recently recommended revising the country’s universal hepatitis B vaccine birth dose policy, a move that has been met with skepticism from experts.
President Trump signed an executive order to reclassify marijuana, marking a significant shift in American drug policy. While this move could facilitate more research into cannabis, it has faced criticism from anti-legalization groups. Meanwhile, the nation’s first nonprofit offering supervised drug consumption services celebrated its fourth anniversary, despite facing challenges from the federal government.
In a concerning development, political appointees are now reviewing drug applications at the FDA, disrupting the traditional process led by career scientists. This intervention raises questions about the safety and efficacy of drugs under review. On a more positive note, underground AIDS researchers have provided valuable lessons on adapting to funding crises, emphasizing the importance of unconventional partnerships and funding streams.
As we wrap up, here are some articles worth checking out:
– NIH funding rates for early-career researchers have plunged in 2025.
– Eli Lilly’s obesity pill has shown promising results in helping patients maintain weight loss.
– New York is set to legalize medically assisted suicide with ‘guardrails.’
– Immigrants are avoiding medical care due to fears of deportation.
– Republicans are facing challenges after a setback on ACA.
Stay informed and stay healthy with these latest updates in health and medicine.
